相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trans-eQTLs of the CYP3A4 and CYP3A5 associated with tacrolimus trough blood concentration in Chinese renal transplant patients
Huijie Lu et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
ESR1 ChIP-Seq Identifies Distinct Ligand-Free ESR1 Genomic Binding Sites in Human Hepatocytes and Liver Tissue
Joseph M. Collins et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Functional CYP3A variants affecting tacrolimus trough blood concentrations in Chinese renal transplant recipients
Dina Chen et al.
PHARMACOGENOMICS JOURNAL (2021)
4See: A Flexible Browser to Explore 4C Data
Yousra Ben Zouari et al.
FRONTIERS IN GENETICS (2020)
Cis-acting regulatory elements regulating CYP3A4 transcription in human liver
Joseph M. Collins et al.
PHARMACOGENETICS AND GENOMICS (2020)
Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans
Johannes Matthaei et al.
FRONTIERS IN GENETICS (2020)
Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review
Sylvia D. Klomp et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Ligand-Free Estrogen Receptor α (ESR1) as Master Regulator for the Expression of CYP3A4 and Other Cytochrome P450 Enzymes in the Human Liver
Danxin Wang et al.
MOLECULAR PHARMACOLOGY (2019)
Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis
Rongbin Zheng et al.
NUCLEIC ACIDS RESEARCH (2019)
ZNF143 is a regulator of chromatin loop
Zi Wen et al.
CELL BIOLOGY AND TOXICOLOGY (2018)
Interactions Between Regulatory Variants in CYP7A1 (Cholesterol 7 alpha-Hydroxylase) Promoter and Enhancer Regions Regulate CYP7A1 Expression
Danxin Wang et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity
Fumitaka Inoue et al.
GENOME RESEARCH (2017)
Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery
Ogheneochukome Lolodi et al.
CURRENT DRUG METABOLISM (2017)
CYP3A4 intronic SNP rs35599367 (CYP3A4☆22) alters RNA splicing
Danxin Wang et al.
PHARMACOGENETICS AND GENOMICS (2016)
Systematic mapping of functional enhancer-promoter connections with CRISPR interference
Charles P. Fulco et al.
SCIENCE (2016)
A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
A promoter-level mammalian expression atlas
Alistair R. R. Forrest et al.
NATURE (2014)
Chromatin accessibility: a window into the genome
Maria Tsompana et al.
EPIGENETICS & CHROMATIN (2014)
Genome-Wide Discovery of Drug-Dependent Human Liver Regulatory Elements
Robin P. Smith et al.
PLOS GENETICS (2014)
Expression of Hepatic Drug-Metabolizing Cytochrome P450 Enzymes and Their Intercorrelations: A Meta-Analysis
Brahim Achour et al.
DRUG METABOLISM AND DISPOSITION (2014)
ENCODE Data in the UCSC Genome Browser: year 5 update
Kate R. Rosenbloom et al.
NUCLEIC ACIDS RESEARCH (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
The accessible chromatin landscape of the human genome
Robert E. Thurman et al.
NATURE (2012)
HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants
Lucas D. Ward et al.
NUCLEIC ACIDS RESEARCH (2012)
Transcription factor binding at enhancers: shaping a genomic regulatory landscape in flux
Robert-Jan Palstra et al.
Frontiers in Genetics (2012)
Genetic epidemiology of induced CYP3A4 activity
Nilufer Rahmioglu et al.
PHARMACOGENETICS AND GENOMICS (2011)
Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
D. Wang et al.
PHARMACOGENOMICS JOURNAL (2011)
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
Pertti J. Neuvonen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
The human intestinal cytochrome P450 pie
MF Paine et al.
DRUG METABOLISM AND DISPOSITION (2006)
Identification of a novel polymorphic enhancer of the human CYP3A4 gene
K Matsumura et al.
MOLECULAR PHARMACOLOGY (2004)
The human genome browser at UCSC
WJ Kent et al.
GENOME RESEARCH (2002)
Common allelic variants of cytochrome P4503A4 and their prevalence in different populations
JK Lamba et al.
PHARMACOGENETICS (2002)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
Evaluation of the genetic component of variability in CYP3A4 activity:: a repeated drug administration method
V Özdemir et al.
PHARMACOGENETICS (2000)
分享论文
